The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

AZN FINANCIAL STATEMENTS

AstraZeneca PLC — balance sheet, income statement and cash flow trends

AZNAstraZeneca PLC

🇸🇪 Sweden · ST · Healthcare · Drug Manufacturers - General

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
020 B40 B60 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue61.3 B $Gross Profit50.2 B $ · 82%Operating Income14 B $ · 23%Pre-tax Income12.6 B $ · 21%Net Income to Owners10.4 B $ · 17%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue61.3 B $+8.5%
Gross Profit50.2 B $+9.1%
Operating Income14 B $+23.4%
EBITDA20.6 B $+21.4%
Net Income to Owners10.4 B $+25.9%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 B100 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets116.9 B
  • Equity50.7 B $43%
  • Current Liabilities31.8 B $27%
  • Long-term Liabilities34.2 B $29%

Key Figures

YoY change
Total Assets116.9 B $+3.9%
Total Liabilities66 B $-2.3%
Total Equity50.7 B $+13.5%
Cash & ST Investments5 B $-29.5%
Total Debt32.5 B $-1.0%
Net Debt27.6 B $+7.0%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
05 B10 B15 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
05 B10 B13.8 B $Operating-8.2 B $Investing-7.7 B $Financing-2.1 B $Net Change

Key Figures

YoY change
Operating Cash Flow13.8 B $+2.7%
Capital Expenditures4.3 B $-17.9%
Free Cash Flow9.5 B $+15.8%
Dividends Paid4.9 B $-0.6%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on AZN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.